AAAAAA
Results: 1-25/27
Authors:
SPIGSET O
HAGG S
Citation: O. Spigset et S. Hagg, EXCRETION OF PSYCHOTROPIC-DRUGS INTO BREAST-MILK - PHARMACOKINETIC OVERVIEW AND THERAPEUTIC IMPLICATIONS, CNS DRUGS, 9(2), 1998, pp. 111-134
Authors:
SPIGSET O
GRANBERG K
HAGG S
SODERSTROM E
DAHLQVIST R
Citation: O. Spigset et al., NONLINEAR FLUVOXAMINE DISPOSITION, British journal of clinical pharmacology, 45(3), 1998, pp. 257-263
Authors:
HAGG S
JOELSSON L
MJORNDAL T
SPIGSET O
OJA G
DAHLQVIST R
Citation: S. Hagg et al., PREVALENCE OF DIABETES AND IMPAIRED GLUCOSE-TOLERANCE IN PATIENTS TREATED WITH CLOZAPINE COMPARED WITH PATIENTS TREATED WITH CONVENTIONAL DEPOT NEUROLEPTIC MEDICATIONS, The Journal of clinical psychiatry, 59(6), 1998, pp. 294-299
Authors:
SPIGSET O
Citation: O. Spigset, ARE ADVERSE DRUG-REACTIONS ATTRIBUTED TO FLUVOXAMINE CAUSED BY CONCOMITANT INTAKE OF CAFFEINE, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 665-666
Authors:
SPIGSET O
ALLARD P
MJORNDAL T
Citation: O. Spigset et al., CIRCANNUAL VARIATIONS IN THE BINDING OF [H-3]LYSERGIC ACID DIETHYLAMIDE TO SEROTONIN(2A) RECEPTORS AND OF [H-3]PAROXETINE TO SEROTONIN UPTAKE SITES IN PLATELETS FROM HEALTHY-VOLUNTEERS, Biological psychiatry, 43(10), 1998, pp. 774-780
Authors:
SPIGSET O
MJORNDAL T
Citation: O. Spigset et T. Mjorndal, EFFECT OF FLUVOXAMINE ON PLATELET 5-HT2A RECEPTORS AS STUDIED BY [H-3] LYSERGIC-ACID DIETHYLAMIDE ([H-3]LSD) BINDING IN HEALTHY-VOLUNTEERS, Psychopharmacology, 133(1), 1997, pp. 39-42
Authors:
SPIGSET O
MJORNDAL T
Citation: O. Spigset et T. Mjorndal, SEROTONIN 5-HT2A RECEPTOR-BINDING IN PLATELETS FROM HEALTHY-SUBJECTS AS STUDIED BY [H-3] LYSERGIC-ACID DIETHYLAMIDE ([H-3]-LSD) - INTRA-INDIVIDUAL AND INTERINDIVIDUAL VARIABILITY, Neuropsychopharmacology, 16(4), 1997, pp. 285-293
Authors:
SPIGSET O
CARLEBORG L
OHMAN R
NORSTROM A
Citation: O. Spigset et al., EXCRETION OF CITALOPRAM IN BREAST-MILK, British journal of clinical pharmacology, 44(3), 1997, pp. 295-298
Authors:
SPIGSET O
VONSCHEELE C
Citation: O. Spigset et C. Vonscheele, LEVODOPA DEPENDENCE AND ABUSE IN PARKINSONS-DISEASE, Pharmacotherapy, 17(5), 1997, pp. 1027-1030
Authors:
SPIGSET O
HEDENMALM K
Citation: O. Spigset et K. Hedenmalm, HYPONATREMIA IN RELATION TO TREATMENT WITH ANTIDEPRESSANTS - A SURVEYOF REPORTS IN THE WORLD-HEALTH-ORGANIZATION DATA-BASE FOR SPONTANEOUSREPORTING OF ADVERSE DRUG-REACTIONS, Pharmacotherapy, 17(2), 1997, pp. 348-352
Authors:
SPIGSET O
MJORNDAL T
Citation: O. Spigset et T. Mjorndal, THE EFFECT OF FLUVOXAMINE ON SERUM PROLACTIN AND SERUM SODIUM CONCENTRATIONS - RELATION TO PLATELET 5-HT2A RECEPTOR STATUS, Journal of clinical psychopharmacology, 17(4), 1997, pp. 292-297
Authors:
SPIGSET O
ADIELSSON G
Citation: O. Spigset et G. Adielsson, COMBINED SEROTONIN SYNDROME AND HYPONATREMIA CAUSED BY A CITALOPRAM-BUSPIRONE INTERACTION, International clinical psychopharmacology, 12(1), 1997, pp. 61-63
URINARY-EXCRETION OF CODEINE, ETHYLMORPHINE, AND THEIR METABOLITES - RELATION TO THE CYP2D6 ACTIVITY
Authors:
HEDENMALM K
SUNDGREN M
GRANBERG K
SPIGSET O
DAHLQVIST R
Citation: K. Hedenmalm et al., URINARY-EXCRETION OF CODEINE, ETHYLMORPHINE, AND THEIR METABOLITES - RELATION TO THE CYP2D6 ACTIVITY, Therapeutic drug monitoring, 19(6), 1997, pp. 643-649
Authors:
SPIGSET O
GRANBERG K
HAGG S
NORSTROM A
DAHLQVIST R
Citation: O. Spigset et al., RELATIONSHIP BETWEEN FLUVOXAMINE PHARMACOKINETICS AND CYP2D6 CYP2C19 PHENOTYPE POLYMORPHISMS/, European Journal of Clinical Pharmacology, 52(2), 1997, pp. 129-133
Authors:
SPIGSET O
HEDENMALM K
DAHL ML
WIHOLM BE
DAHLQVIST R
Citation: O. Spigset et al., SEIZURES AND MYOCLONUS ASSOCIATED WITH ANTIDEPRESSANT TREATMENT - ASSESSMENT OF POTENTIAL RISK-FACTORS, INCLUDING CYP2D6 AND CYP2C19 POLYMORPHISMS, AND TREATMENT WITH CYP2D6 INHIBITORS, Acta psychiatrica Scandinavica, 96(5), 1997, pp. 379-384
Authors:
PLEYM H
SPIGSET O
Citation: H. Pleym et O. Spigset, PERIPHERAL NEUROLOGIC DEFICITS IN RELATION TO SUBARACHNOID OR EPIDURAL ADMINISTRATION OF LOCAL-ANESTHETICS FOR SURGERY - A SURVEY OF 21 CASES, Acta anaesthesiologica Scandinavica, 41(4), 1997, pp. 453-460
Authors:
HEDENMALM K
SPIGSET O
Citation: K. Hedenmalm et O. Spigset, PERIPHERAL SENSORY DISTURBANCES RELATED TO TREATMENT WITH FLUOROQUINOLONES, Journal of antimicrobial chemotherapy, 37(4), 1996, pp. 831-837
Authors:
SPIGSET O
HEDENMALM K
Citation: O. Spigset et K. Hedenmalm, HYPONATREMIA DURING TREATMENT WITH CLOMIPRAMINE, PERPHENAZINE, OR CLOZAPINE - STUDY OF THERAPEUTIC DRUG-MONITORING SAMPLES, Journal of clinical psychopharmacology, 16(5), 1996, pp. 412-414
Authors:
SPIGSET O
OHMAN R
Citation: O. Spigset et R. Ohman, A CASE OF FLUVOXAMINE INTOXICATION DEMONSTRATING NONLINEAR ELIMINATION PHARMACOKINETICS, Journal of clinical psychopharmacology, 16(3), 1996, pp. 254-255
Authors:
SPIGSET O
CARLEBORG L
NORSTROM A
SANDLUND M
Citation: O. Spigset et al., PAROXETINE LEVEL IN BREAST-MILK, The Journal of clinical psychiatry, 57(1), 1996, pp. 39-39
Authors:
OSTROM M
ERIKSSON A
THORSON J
SPIGSET O
Citation: M. Ostrom et al., FATAL OVERDOSE WITH CITALOPRAM, Lancet, 348(9023), 1996, pp. 339-340
Authors:
SPIGSET O
HEDENMALM K
Citation: O. Spigset et K. Hedenmalm, HYPONATREMIA AND THE SYNDROME OF INAPPROPRIATE ANTIDIURETIC-HORMONE SECRETION (SIADH) INDUCED BY PSYCHOTROPIC-DRUGS, Drug safety, 12(3), 1995, pp. 209-225
Authors:
SPIGSET O
CARLEBORG L
HEDENMALM I
DAHLQVIST R
Citation: O. Spigset et al., EFFECT OF CIGARETTE SMOLTING ON FLUVOXAMINE PHARMACOKINETICS IN HUMANS, Clinical pharmacology and therapeutics, 58(4), 1995, pp. 399-403
Authors:
SPIGSET O
CARLEBORG L
MJORNDAL T
NORSTROM A
SUNDGREN M
Citation: O. Spigset et al., CARBAMAZEPINE INTERFERENCE IN A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ANALYSIS FOR PERPHENAZINE, Therapeutic drug monitoring, 16(3), 1994, pp. 332-333
Authors:
SPIGSET O
Citation: O. Spigset, REDUCED EFFECT OF WARFARIN CAUSED BY UBIDECARENONE, Lancet, 344(8933), 1994, pp. 1372-1373